Paul T Hardy1, Kathleen M Weil. 1. U.S. Food and Drug Administration, Center for Devices and Radiologic Health, Office of Surveillance and Biometrics, Division of Postmarket Surveillance, Silver Spring, Maryland, USA.
Authors: Fabian Kording; Bjoern P Schoennagel; Manuela Tavares de Sousa; Kai Fehrs; Gerhard Adam; Jin Yamamura; Christian Ruprecht Journal: Magn Reson Med Sci Date: 2018-02-21 Impact factor: 2.471